Literature DB >> 1432487

Determination of plasma (1-->3)-beta-D-glucan: a new diagnostic aid to deep mycosis.

T Obayashi1, M Yoshida, H Tamura, J Aketagawa, S Tanaka, T Kawai.   

Abstract

We present additional evidence that plasma from patients with deep-seated mycoses contains (1-->3)-beta-D-glucan. Digestion of such samples with endo-(1-->3)-beta-D-glucanase completely abolished the ability of the plasma to activate factor-G, a horseshoe crab coagulation enzyme that is extremely sensitive to this polysaccharide. Measurement of plasma (1-->3)-beta-D-glucan is a promising method for the diagnosis of deep-seated mycoses and for monitoring the response of these infections to antifungal therapy.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1432487     DOI： 10.1080/02681219280000361

Source DB:  PubMed          Journal:  J Med Vet Mycol        ISSN： 0268-1218


  22 in total

1.  Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting.

Authors:  John F Mohr; Charles Sims; Victor Paetznick; Jose Rodriguez; Malcolm A Finkelman; John H Rex; Luis Ostrosky-Zeichner
Journal:  J Clin Microbiol       Date:  2010-11-03       Impact factor: 5.948

Review 2.  Aspergillus infections in transplant recipients.

Authors:  Nina Singh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Alzheimer's disease and disseminated mycoses.

Authors:  R Alonso; D Pisa; A Rábano; L Carrasco
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-23       Impact factor: 3.267

4.  Bacterial translocation: not a clinically relevant phenomenon in colorectal cancer.

Authors:  Yoshio Takesue; Masayuki Kakehashi; Hiroki Ohge; Kenichiro Uemura; Yuuji Imamura; Yoshiaki Murakami; Masaru Sasaki; Masahiko Morifuji; Yujiro Yokoyama; Mohei Kouyama; Kazuya Okii; Taijiro Sueda
Journal:  World J Surg       Date:  2005-02       Impact factor: 3.352

5.  Clinical and experimental studies of the limulus test after digestive surgery.

Authors:  Y Kimura; A Nakao; H Tamura; S Tanaka; H Takagi
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

Review 6.  Diagnosis of invasive mycoses in severely immunosuppressed patients.

Authors:  R Rüchel
Journal:  Ann Hematol       Date:  1993-07       Impact factor: 3.673

7.  Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.

Authors:  Jerry W Pickering; Howard W Sant; Catherine A P Bowles; William L Roberts; Gail L Woods
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

8.  Comparison between Wako-WB003 and Fungitec G tests for detection of (1-->3)-beta-D-glucan in systemic mycosis.

Authors:  M A Hossain; T Miyazaki; K Mitsutake; H Kakeya; Y Yamamoto; K Yanagihara; S Kawamura; T Otsubo; Y Hirakata; T Tashiro; S Kohno
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

9.  Plasma (1-->3)-beta-D-glucan assay and immunohistochemical staining of (1-->3)-beta-D-glucan in the fungal cell walls using a novel horseshoe crab protein (T-GBP) that specifically binds to (1-->3)-beta-D-glucan.

Authors:  H Tamura; S Tanaka; T Ikeda; T Obayashi; Y Hashimoto
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

10.  Competitive binding inhibition enzyme-linked immunosorbent assay that uses the secreted aspartyl proteinase of Candida albicans as an antigenic marker for diagnosis of disseminated candidiasis.

Authors:  Christine J Morrison; Steven F Hurst; Errol Reiss
Journal:  Clin Diagn Lab Immunol       Date:  2003-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.